𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blood transfusion and disease-free survival in carcinoma of the breast

✍ Scribed by Michael M. Nowak; Jeffrey L. Ponsky


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
554 KB
Volume
27
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


A retrospective study was undertaken to determine the effect of perioperative blood transfusion on disease-free survival rates in patients with carcinoma of the breast. The charts of 81 patients participating in a NSABP breast cancer protocol at The Mt. Sinai Medical Center, Cleveland, Ohio, were reviewed. There was no statistically significant difference in disease-free survival between those patients receiving blood transfusions and those that did not when considering the entire group of patients or subgroups based upon age, nodal status, estrogen receptor status, or progesterone receptor status. However, the subgroup of patients receiving tamoxifen chemotherapy, especially those with positive estrogen receptors, had significantly reduced disease-free survival (P < .05) when given blood transfusions. These results suggest an adverse effect of blood transfusion on disease-free survival in breast cancer patients treated with tamoxifen chemotherapy.


πŸ“œ SIMILAR VOLUMES


Perioperative blood transfusion in hepat
✍ A-Hon Kwon; Yoichi Matsui; Yasuo Kamiyama πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

## BACKGROUND. The postoperative recurrence of hepatocellular carcinomas (HCC) associated with perioperative blood transfusion has been the subject of controversy. The authors prospectively investigated the relation between perioperative allogeneic blood transfusions, the recurrence free survival,

Prognostic factors affecting survival an
✍ Bekir Kuru; Mithat Camlibel; Mehmet Ali Gulcelik; Haluk Alagol πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract ## Background and Objectives The objective of this study was to identify the patients who are at low or high‐risk by defining the prognostic factors in node‐negative breast carcinomas. ## Methods Medical records of 384 consecutive breast cancer patients with negative axillary lymph n